Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.03.636273

Exploring Synergies in Brain-Machine Interfaces: Compression vs. Performance

Abstract

Individuals with severe neurological injuries often rely on assistive technologies, but current methods have limitations in accurately decoding multi-degree-of-freedom (DoF) movements. Intracortical brain-machine interfaces (iBMIs) use neural signals to provide a more natural control method, but currently struggle with higher-DoF movements--something the brain handles effortlessly. It has been theorized that the brain simplifies high-DoF movement through muscle synergies, which link multiple muscles to function as a single unit. These synergies have been studied using dimensionality reduction techniques like principal component analysis (PCA), non-negative matrix factorization (NMF), and demixed PCA (dPCA) and successfully used to reduce noise and improve offline decoder stability in non-invasive applications. However, their effectiveness in improving decoding and generalizability for implanted recordings across varied tasks is unclear. Here, we evaluated if brain and muscle synergies can enhance iBMI performance in non-human primates performing a two-DoF finger task. Specifically, we tested if PCA, dPCA, and NMF could compress and denoise brain and muscle data and improve decoder generalization across tasks. Our results showed that while all methods effectively compressed data with minimal loss in decoding accuracy, none improved performance through denoising. Additionally, none of the methods enhanced generalization across tasks. These findings suggest that while dimensionality reduction can aid data compression, alone it may not reveal the "true" control space needed to improve decoder performance or generalizability. Further research is required to determine whether synergies are the optimal control framework or if alternative approaches are required to enhance decoder robustness in iBMI applications. Significance StatementMany researchers believe that brain and muscle synergies represent a fundamental control strategy and could enhance brain-machine interface (BMI) decoding performance. These synergies, extracted through dimensionality reduction techniques, are thought to simplify complex neural data, improving the efficiency and accuracy of BMI systems. In our study, we evaluated brain and muscle synergies in a dexterous finger task. We found that while these synergies effectively compressed high-dimensional data, they did not improve performance through denoising or generalize well across different contexts. Instead, the highest performance was achieved when using all available data, suggesting that synergies, although useful for data compression, may not provide the "true" control space needed to enhance decoder robustness or adaptability in implanted BMI systems.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cubillos, L. H., Kelberman, M., Mender, M. J., Hite, A., Temmar, H., Willsey, M., Kumar, N. G., Kung, T. A., Patil, P., Chestek, C. A., Krishnan, C.. 2025-02-03. Exploring Synergies in Brain-Machine Interfaces: Compression vs. Performance. https://doi.org/10.1101/2025.02.03.636273

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗